immune oncology in breast cancer: keynote-086, nci 10013, & aipac
Published 3 years ago • 144 plays • Length 8:01Download video MP4
Download video MP3
Similar videos
-
1:24
nci minute: immunotherapy for metastatic breast cancer
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
4:49
keynote-355: pembro chemo in triple-negative breast cancer
-
4:13
where does immuno-oncology fit in the treatment landscape of tnbc?
-
1:56
next questions in breast cancer treatment
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
1:59
effectiveness of icis in the neoadjuvant and post-neoadjuvant breast cancer setting
-
0:41
the importance of brca-1 testing in triple negative breast cancer
-
1:28
the evolution of immunotherapy for breast cancer
-
18:38
breast cancer esmo 2024 highlights: key studies discussed natalee, keynote 522, destiny-breast12
-
4:01
keynote-355: outcomes in pts discontinuing chemo before pembro and in pts with immune-mediated aes
-
1:42
nci experts discuss challenges in breast cancer research
-
5:01
keynote-522: final os findings of pembrolizumab and chemotherapy in tnbc
-
24:33
20221005 talk with a doc - breast cancer
-
1:46
exploratory analysis of keynote-522: efs after neoadjuvant pembro chemo vs chemo for early tnbc
-
5:01
the human immune system: the missing link in developing breast cancer
-
2:35
circulating tumor cells as a treatment monitoring tool in metastatic breast cancer
-
1:39
encouraging developments in triple negative breast cancer immunotherapy